Results 251 to 260 of about 106,567 (341)

Lack of improvement after short‐term topical antistaphylococcal endolysin SA.100 therapy in patients with mild‐to‐moderate atopic dermatitis: Results from a randomized, vehicle‐controlled trial

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2409-2413, July 2026.
Abstract Atopic dermatitis (AD) is a chronic immune‐mediated inflammatory skin disease. An overgrowth of Staphylococcus aureus (S. aureus) and decreased microbial diversity is apparent in 70%–90% of AD patients. SA.100 is a recombinant endolysin targeting S. aureus that might be a novel treatment for patients with mild‐to‐moderate AD.
Laura W. J. van der Meulen   +15 more
wiley   +1 more source

MRSA Septic Thrombophlebitis and Pulmonary Embolism: A Case Report Highlighting the Tight Bond With Infective Endocarditis

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Septic pulmonary embolism in adults is usually associated with right‐sided endocarditis. We report a 27‐year‐old male with 14 days of fever, dyspnea, and hemoptysis. CT chest showed bilateral peripheral cavitating nodules consistent with septic pulmonary emboli.
Santiago Saenz‐Ancira   +5 more
wiley   +1 more source

Pulmonary Leukemic Infiltration in Relapsed Acute Myeloid Leukemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Pulmonary leukemic infiltration (PLI) is a rare complication of acute myeloid leukemia often misdiagnosed as pneumonia. This case highlights a unique presentation of PLI in a relapsed patient without hyperleukocytosis, necessitating a high index of suspicion.
Masoud Mortezazadeh   +6 more
wiley   +1 more source

Comparison of Adhesion and Virulence of Two Predominant Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clones and Clonal Methicillin-Susceptible S. aureus Isolates

open access: green, 2008
Hatice Karaüzüm   +9 more
openalex   +1 more source

Chiral (Stereoselective) Drugs, Asymmetric Synthesis, and Racemic Resolution Methods

open access: yesChirality, Volume 38, Issue 7, July 2026.
Chirality is crucial in drug development since both biological targets in the organism and the majority of pharmaceutical compounds are chiral. The synthesis and resolution of chiral compounds are critical steps while developing chiral drugs. Asymmetric synthesis and racemic resolution are the two most common methods for obtaining enantiopure drugs ...
Burcu Karayavuz   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy